"Advanced Pharma – Miami is a dedicated Phase I­ Clinical Research Facility, participating in clinical trials since 1992 with more than 50 years of combined experience. Having our multi-­specialty Physician Investigators enables us to engage in many aspects of the Pharmaceutical development, Bio­tech and Medical Device Trials. Our team of experts is dedicated to sustaining safe, ethical and high quality medical research so Sponsors can exceed their deadlines and patients can benefit from the development of new treatments and therapies. We pride ourselves in bringing efficiency, innovation and value to the clinical research process."

During the past decade, Advanced Pharma CR, LLC conducted 47 clinical trials. In the 10-year time frame, 47 clinical trials started and 27 clinical trials were completed, i.e. on average, 57.4% percent of trials that started reached the finish line to date. In the past 5 years, 30 clinical trials started and 12 clinical trials were completed. i.e. 40% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Advanced Pharma CR, LLC" #1 sponsor was "Incyte Corporation" with 7 trials, followed by "Pfizer" with 4 trials sponsored, "Astellas Pharma Global Development, Inc." with 3 trials sponsored, "Eli Lilly and Company" with 3 trials sponsored and "Ferring Pharmaceuticals" with 3 trials sponsored. Other sponsors include 44 different institutions and companies that sponsored additional 45 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Advanced Pharma CR, LLC" #1 collaborator was "Gilead Sciences" with 2 trials as a collaborator, "Integrium" with 2 trials as a collaborator, "Bionomics Limited" with 1 trials as a collaborator, "DSM Nutritional Products, Inc." with 1 trials as a collaborator and "Duke Clinical Research Institute" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Advanced Pharma CR, LLC" are "Hepatic Impairment" (4 trials), "Renal Impairment" (4 trials), "Crohn's Disease" (3 trials), "Healthy Volunteers" (3 trials) and "Sickle Cell Disease" (3 trials). Many other conditions were trialed in "Advanced Pharma CR, LLC" in a lesser frequency.

Most popular intervention types in "Advanced Pharma CR, LLC" are "Drug" (58 trials), "Other" (6 trials), "Biological" (4 trials), "Device" (2 trials) and "Dietary Supplement" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (24 trials), "Parsaclisib" (3 trials), "Elobixibat 10 mg" (2 trials), "Filgotinib" (2 trials) and "NP2" (2 trials). Other intervention names were less common.

The vast majority of trials in "Advanced Pharma CR, LLC" are 66 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Advanced Pharma CR, LLC". undefined are not yet recruiting, 10 are recruiting, 4 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 40 completed trials in Advanced Pharma CR, LLC, undefined suspended trials, and 13 terminated clinical trials to date.

Out of the total trials that were conducted in Advanced Pharma CR, LLC, 25 "Phase 1" clinical trials were conducted, 18 "Phase 2" clinical trials and 23 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 4 trials that are defined as “Not Applicable".